STOCK TITAN

[Form 4] RETRACTABLE TECHNOLOGIES INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Thomas J. Shaw, President and CEO of Retractable Technologies, acquired 5,000 shares of the company's common stock on 09/29/2025 at a weighted average price of $0.8201 under a Rule 10b5-1 plan adopted 08/22/2024. After the transaction, Mr. Shaw directly beneficially owns 15,678,825 shares and indirectly holds 831,600 shares for which he has voting or investment control as Trustee for a family member. The filing was signed by an attorney-in-fact on 09/30/2025.

Thomas J. Shaw, presidente e amministratore delegato di Retractable Technologies, ha acquistato 5.000 azioni delle azioni ordinarie della società il 29/09/2025 a un prezzo medio ponderato di $0.8201 nell’ambito di un piano Rule 10b5-1 adottato il 22/08/2024. Dopo la transazione, il signor Shaw detiene direttamente in modo vantaggioso 15.678.825 azioni e indirettamente 831.600 azioni per le quali esercita controllo di voto o di investimento in qualità di trustee per un familiare. La presentazione è stata firmata da un procuratore il 30/09/2025.

Thomas J. Shaw, presidente y director ejecutivo de Retractable Technologies, adquirió 5.000 acciones de las acciones comunes de la empresa el 29/09/2025 a un precio medio ponderado de $0.8201 dentro de un plan Rule 10b5-1 adoptado el 22/08/2024. Después de la operación, el señor Shaw posee directamente de forma beneficiosa 15,678,825 acciones e indirectamente 831,600 acciones para las que tiene control de voto o de inversión como fiduciario para un familiar. La presentación fue firmada por un apoderado el 30/09/2025.

Retractable Technologies의 사장 겸 최고경영자 Thomas J. Shaw는 2025년 9월 29일에 회사의 보통주 5,000주를 매입했고 2024년 8월 22일에 제정된 Rule 10b5-1 계획에 따라 가중평균 주가 0.8201달러로 거래를 진행했다. 거래 후 Shaw 부장은 직접적으로 15,678,825주를 혜택상 보유하고 있으며, 가족 구성원을 위한 수탁자로서 의결권 또는 투자 통제를 가진 간접 보유주식 831,600주를 보유하고 있다. 서류는 2025년 9월 30일에 대리인이 서명했다.

Thomas J. Shaw, président-directeur général de Retractable Technologies, a acquis 5 000 actions ordinaires de la société le 29/09/2025 à un cours moyen pondéré de 0,8201 $ dans le cadre d’un plan Rule 10b5-1 adopté le 22/08/2024. Après la transaction, M. Shaw détient directement 15 678 825 actions et indirectement 831 600 actions pour lesquelles il exerce un contrôle de vote ou d’investissement en tant que fiduciaire pour un membre de sa famille. Le dossier a été signé par un mandataire le 30/09/2025.

Thomas J. Shaw, Präsident und CEO von Retractable Technologies, hat am 29.09.2025 5.000 Aktien der Stammaktie des Unternehmens zu einem gewichteten Durchschnittspreis von $0,8201 im Rahmen eines am 22.08.2024 eingeführten Rule 10b5-1 Plans erworben. Nach der Transaktion besitzt Dr. Shaw direkt vorteilhaft 15.678.825 Aktien und indirekt 831.600 Aktien, für die er als Treuhänder für ein Familienmitglied Stimm- oder Anlagekontrolle ausübt. Die Einreichung wurde am 30.09.2025 von einem Bevollmächtigten unterzeichnet.

Thomas J. Shaw، الرئيس التنفيذي لشركة Retractable Technologies، اشترى 5,000 سهماً من أسهم الشركة العادية في 29/09/2025 بسعر متوسط مرجّح قدره 0.8201 دولار ضمن خطة Rule 10b5-1 التي اعتمدت في 22/08/2024. بعد الصفقة، يمتلك السيد شاو بشكل مباشر وبشكل فعّال 15,678,825 سهماً وبشكل غير مباشر 831,600 سهم له حقوق التصويت أو الاستثمار كوصي لصالح أحد أفراد العائلة. تم توقيع الملف من قبل وكيل قضائي في 30/09/2025.

Thomas J. Shaw,Retractable Technologies 的总裁兼首席执行官,于2025年9月29日以加权平均价格0.8201美元,在公司普通股下购买了5,000股,依据于2024年8月22日通过的Rule 10b5-1计划。 交易完成后,Shaw先生直接持有并从中获益15,678,825股,间接持有831,600股,作为某位家庭成员的受托人对其投票权或投资控制权。该申报书于2025年9月30日由代理人签署。

Positive
  • CEO purchased 5,000 shares on 09/29/2025 at a weighted average price of $0.8201.
  • Direct beneficial ownership reported at 15,678,825 shares after the transaction, showing substantial insider stake.
  • Indirect holdings of 831,600 shares disclosed with explanation of Trustee investment power and voting agreement.
  • Transaction executed under a Rule 10b5-1 plan adopted 08/22/2024, indicating a pre-established trading plan.
Negative
  • None.

Insights

TL;DR: CEO purchased 5,000 shares at $0.8201 under a pre-existing 10b5-1 plan, slightly increasing direct ownership.

The purchase is modest relative to the CEO's total direct stake of 15.7 million shares, so the transaction is unlikely to materially change ownership percentages or control. The use of a Rule 10b5-1 plan indicates the trade was pre-planned and may reduce concerns about opportunistic timing. Investors should note the reported weighted average price and the combined direct and indirect holdings disclosed.

TL;DR: Insider transaction follows a documented 10b5-1 plan and discloses both direct and indirect holdings clearly.

The filing specifies that Mr. Shaw has voting control over the bulk of his holdings and investment power over 500,000 shares as Trustee for a family member, which clarifies potential conflicts and control structure. The signature by an attorney-in-fact is properly noted. The disclosure is complete for the reported transaction and ownership breakdown.

Thomas J. Shaw, presidente e amministratore delegato di Retractable Technologies, ha acquistato 5.000 azioni delle azioni ordinarie della società il 29/09/2025 a un prezzo medio ponderato di $0.8201 nell’ambito di un piano Rule 10b5-1 adottato il 22/08/2024. Dopo la transazione, il signor Shaw detiene direttamente in modo vantaggioso 15.678.825 azioni e indirettamente 831.600 azioni per le quali esercita controllo di voto o di investimento in qualità di trustee per un familiare. La presentazione è stata firmata da un procuratore il 30/09/2025.

Thomas J. Shaw, presidente y director ejecutivo de Retractable Technologies, adquirió 5.000 acciones de las acciones comunes de la empresa el 29/09/2025 a un precio medio ponderado de $0.8201 dentro de un plan Rule 10b5-1 adoptado el 22/08/2024. Después de la operación, el señor Shaw posee directamente de forma beneficiosa 15,678,825 acciones e indirectamente 831,600 acciones para las que tiene control de voto o de inversión como fiduciario para un familiar. La presentación fue firmada por un apoderado el 30/09/2025.

Retractable Technologies의 사장 겸 최고경영자 Thomas J. Shaw는 2025년 9월 29일에 회사의 보통주 5,000주를 매입했고 2024년 8월 22일에 제정된 Rule 10b5-1 계획에 따라 가중평균 주가 0.8201달러로 거래를 진행했다. 거래 후 Shaw 부장은 직접적으로 15,678,825주를 혜택상 보유하고 있으며, 가족 구성원을 위한 수탁자로서 의결권 또는 투자 통제를 가진 간접 보유주식 831,600주를 보유하고 있다. 서류는 2025년 9월 30일에 대리인이 서명했다.

Thomas J. Shaw, président-directeur général de Retractable Technologies, a acquis 5 000 actions ordinaires de la société le 29/09/2025 à un cours moyen pondéré de 0,8201 $ dans le cadre d’un plan Rule 10b5-1 adopté le 22/08/2024. Après la transaction, M. Shaw détient directement 15 678 825 actions et indirectement 831 600 actions pour lesquelles il exerce un contrôle de vote ou d’investissement en tant que fiduciaire pour un membre de sa famille. Le dossier a été signé par un mandataire le 30/09/2025.

Thomas J. Shaw, Präsident und CEO von Retractable Technologies, hat am 29.09.2025 5.000 Aktien der Stammaktie des Unternehmens zu einem gewichteten Durchschnittspreis von $0,8201 im Rahmen eines am 22.08.2024 eingeführten Rule 10b5-1 Plans erworben. Nach der Transaktion besitzt Dr. Shaw direkt vorteilhaft 15.678.825 Aktien und indirekt 831.600 Aktien, für die er als Treuhänder für ein Familienmitglied Stimm- oder Anlagekontrolle ausübt. Die Einreichung wurde am 30.09.2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
SHAW THOMAS J

(Last) (First) (Middle)
511 LOBO LANE

(Street)
LITTLE ELM TX 75068

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RETRACTABLE TECHNOLOGIES INC [ RVP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
PRESIDENT AND CEO
3. Date of Earliest Transaction (Month/Day/Year)
09/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/29/2025 P 5,000 A $0.8201(1) 15,678,825 D
Common Stock 831,600 I Voting or Investment Control(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents weighted average price.
2. Mr. Shaw has investment power over 500,000 shares as Trustee for the benefit of a family member. Mr. Shaw has voting control over the remainder of the shares pursuant to a voting agreement.
Remarks:
The Rule 10b5-1 Plan's date of adoption was August 22, 2024.
/s/ D. Valerie Thomas, Attorney-in-Fact 09/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did RVP (Retractable Technologies) report on 09/29/2025?

The company's President and CEO, Thomas J. Shaw, acquired 5,000 shares on 09/29/2025 at a weighted average price of $0.8201 under a Rule 10b5-1 plan.

How many shares does Thomas J. Shaw beneficially own after the Form 4 filing?

Following the reported transaction, Mr. Shaw directly beneficially owns 15,678,825 shares and indirectly beneficially owns 831,600 shares.

Was the trade part of a prearranged plan?

Yes. The filing states the trade was made under a Rule 10b5-1 plan adopted on 08/22/2024.

Does Mr. Shaw have voting or investment control over indirect holdings?

Yes. The filing states Mr. Shaw has investment power over 500,000 shares as Trustee for a family member and voting control over the remainder pursuant to a voting agreement.

Who signed the Form 4 and when?

The Form 4 was signed by D. Valerie Thomas, Attorney-in-Fact on 09/30/2025.
Retractable Tech

NYSE:RVP

RVP Rankings

RVP Latest News

RVP Latest SEC Filings

RVP Stock Data

25.12M
12.69M
57.53%
6.98%
0.13%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
LITTLE ELM